吉利德科学（GILD）今日盘中大跌5.21%，引发市场广泛关注。这一显著跌幅主要源于美国总统特朗普再次威胁对进口药品征收"重大"关税，导致整个制药行业股价受挫。
据报道，特朗普重申计划对所有药品进口征收关税，这是继其"对等"关税生效后的又一举措。特朗普表示，征收关税将激励制药公司将业务转移回美国。这一声明引发了投资者对制药行业未来盈利能力的担忧，导致包括吉利德科学在内的多家制药巨头股价下跌。
受此消息影响，其他美国制药公司股价也出现不同程度的下跌。礼来公司下跌1.5%，百健下跌1.1%，辉瑞下跌1.1%。此外，安进股价下跌2.3%，默克下跌2%，艾伯维下跌2.5%。然而，券商BMO Capital Markets指出，对药品征收关税"可能不会对制造业回流美国产生多大影响"，因为美国已经拥有强大的生物制造和在岸加工能力。尽管如此，市场对这一潜在政策变化的反应仍然谨慎，导致制药股整体承压。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.